AJ Lanigan: Indeed. Actually, Pharma firms are producing huge cash with treatments like Keytruda and Opdivo that offer with PD-1 and PD-L1. Below’s the super great component: think about checkpoints as targeted visitors indicators. You don’t want an immune method that’s jogging wild like a freight practice over a cliff. waiting for link from Social Bookmarking (3)